Adopting Emerging Therapies in Dry Eye Care

In this closing segment, the expert panel reflects on how clinicians can confidently introduce new dry eye therapies into practice while keeping care simple, approachable, and effective. The faculty emphasize that the only way to truly understand a new medication is through real-world experience: prescribing it broadly—not just as a last-resort “Hail Mary”—and observing how different patient types respond. They encourage clinicians to start with straightforward cases, learn from patient feedback, and avoid relying solely on clinical trial expectations. The panel highlights the value of “dry eye ambassadors”—long-term, highly engaged patients who can test new treatments and even share their experiences with others. They also stress the importance of team preparedness, recommending that practices educate staff, utilize industry support, and establish clear workflows to prevent access barriers. Ultimately, the experts agree that success in dry eye management hinges on simplicity, curiosity, strong patient communication, and building a supportive clinical environment where both clinicians and patients feel empowered.